Beactica Therapeutics
Pre-clinicalBeactica Therapeutics is a precision medicine company developing novel small molecule therapeutics to treat life-threatening diseases with significant unmet clinical need.
Founded
2012
Focus
Small Molecules
About
Beactica Therapeutics is a precision medicine company developing novel small molecule therapeutics to treat life-threatening diseases with significant unmet clinical need.
Funding History
4Total raised: $22M
Series A$8MIndustrifondenJun 15, 2021
Series A$8.5MIndustrifondenFeb 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Seed$3MUppsala University HoldingMay 15, 2016
Company Info
TypePrivate
Founded2012
LocationUppsala, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile